In a recent study it was found that many adults in recovery from drugs and alcohol still experienced discrimination as…More
According to Bronte-Hall, the drug allows for greater oxygen delivery and an indirect increase in the hemoglobin. As a result,…More
A small number of men with advanced prostate cancer respond very well to the immunotherapy drug pembrolizumab, according to a…More
Ready for a drug pricing showdown in the House of Representatives? Democrats plan to vote this week on House Speaker…More
Gilead and HHS have had a busy year in PrEP, including a patent lawsuit, but now they’re starting a program…More
The DOJ’s generics price fixing probe has been playing out for years, and this week authorities unveiled a new settlement…More
As lawmakers and the Trump administration debate drug pricing proposals, White House economic advisers have published unfavorable findings on House…More
It’s a familiar scene in the race onto China’s national reimbursement list: Drugmakers cut prices by an average 60.7% to…More
In this week’s FiercePharmaPolitics, an analyst outlines how current drug pricing proposals would affect the industry, plus more. Some proposals…More
The Institute for Clinical and Economic Review (ICER) released the latest iteration of its draft assessment of the cost effectiveness…More
